These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 33662414)
1. Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands. Xiao S; Lu Y; Wu Q; Yang J; Chen J; Zhong S; Eliezer D; Tan Q; Wu C Int J Biol Macromol; 2021 May; 178():381-393. PubMed ID: 33662414 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory Effects of Isobavachalcone on Tau Protein Aggregation, Tau Phosphorylation, and Oligomeric Tau-Induced Apoptosis. Xiao S; Wu Q; Yao X; Zhang J; Zhong W; Zhao J; Liu Q; Zhang M ACS Chem Neurosci; 2021 Jan; 12(1):123-132. PubMed ID: 33320518 [TBL] [Abstract][Full Text] [Related]
3. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design. Wang D; Huang X; Yan L; Zhou L; Yan C; Wu J; Su Z; Huang Y Protein J; 2021 Oct; 40(5):656-668. PubMed ID: 34401998 [TBL] [Abstract][Full Text] [Related]
4. Transition metal nickel prevents Tau aggregation in Alzheimer's disease. Gorantla NV; Das R; Balaraman E; Chinnathambi S Int J Biol Macromol; 2020 Aug; 156():1359-1365. PubMed ID: 31770557 [TBL] [Abstract][Full Text] [Related]
5. β-Sheet core of tau paired helical filaments revealed by solid-state NMR. Daebel V; Chinnathambi S; Biernat J; Schwalbe M; Habenstein B; Loquet A; Akoury E; Tepper K; Müller H; Baldus M; Griesinger C; Zweckstetter M; Mandelkow E; Vijayan V; Lange A J Am Chem Soc; 2012 Aug; 134(34):13982-9. PubMed ID: 22862303 [TBL] [Abstract][Full Text] [Related]
6. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils. Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222 [TBL] [Abstract][Full Text] [Related]
7. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents. Jouanne M; Rault S; Voisin-Chiret AS Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454 [TBL] [Abstract][Full Text] [Related]
8. On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network Investigations. Fagnen C; Giovannini J; Catto M; Voisin-Chiret AS; Sopkova-de Oliveira Santos J ACS Chem Neurosci; 2022 Oct; 13(19):2874-2887. PubMed ID: 36153969 [TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers. Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746 [TBL] [Abstract][Full Text] [Related]
10. Structural study of the recognition mechanism of tau antibody Tau2r3 with the key sequence (VQIINK) in tau aggregation. Tsuchida T; Susa K; Kibiki T; Tsuchiya T; Miyamoto K; In Y; Minoura K; Taniguchi T; Ishida T; Tomoo K Biochem Biophys Res Commun; 2021 Dec; 585():36-41. PubMed ID: 34784549 [TBL] [Abstract][Full Text] [Related]
11. Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease. Harrington CR; Storey JM; Clunas S; Harrington KA; Horsley D; Ishaq A; Kemp SJ; Larch CP; Marshall C; Nicoll SL; Rickard JE; Simpson M; Sinclair JP; Storey LJ; Wischik CM J Biol Chem; 2015 Apr; 290(17):10862-75. PubMed ID: 25759392 [TBL] [Abstract][Full Text] [Related]
12. Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation. Son SH; Do JM; Yoo JN; Lee HW; Kim NK; Yoo HS; Gee MS; Kim JH; Seong JH; Inn KS; Seo MD; Lee JK; Kim NJ Bioorg Chem; 2021 Aug; 113():105022. PubMed ID: 34098397 [TBL] [Abstract][Full Text] [Related]
13. Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology. Das R; Balmik AA; Chinnathambi S Int J Biol Macromol; 2020 Jun; 152():30-39. PubMed ID: 32044365 [TBL] [Abstract][Full Text] [Related]
14. Hsp40s play complementary roles in the prevention of tau amyloid formation. Irwin R; Faust O; Petrovic I; Wolf SG; Hofmann H; Rosenzweig R Elife; 2021 Aug; 10():. PubMed ID: 34369377 [TBL] [Abstract][Full Text] [Related]
15. Pseudophosphorylation of tau protein directly modulates its aggregation kinetics. Chang E; Kim S; Schafer KN; Kuret J Biochim Biophys Acta; 2011 Feb; 1814(2):388-95. PubMed ID: 20974297 [TBL] [Abstract][Full Text] [Related]
16. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease. Dammers C; Yolcu D; Kukuk L; Willbold D; Pickhardt M; Mandelkow E; Horn AH; Sticht H; Malhis MN; Will N; Schuster J; Funke SA PLoS One; 2016; 11(12):e0167432. PubMed ID: 28006031 [TBL] [Abstract][Full Text] [Related]
17. In vitro aggregation assays using hyperphosphorylated tau protein. Sui D; Liu M; Kuo MH J Vis Exp; 2015 Jan; (95):e51537. PubMed ID: 25590418 [TBL] [Abstract][Full Text] [Related]
18. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. Cornejo A; Jiménez JM; Caballero L; Melo F; Maccioni RB J Alzheimers Dis; 2011; 27(1):143-53. PubMed ID: 21785188 [TBL] [Abstract][Full Text] [Related]
19. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. Dominguez-Meijide A; Vasili E; König A; Cima-Omori MS; Ibáñez de Opakua A; Leonov A; Ryazanov S; Zweckstetter M; Griesinger C; Outeiro TF Sci Rep; 2020 Jul; 10(1):12827. PubMed ID: 32732936 [TBL] [Abstract][Full Text] [Related]
20. Structurally Distinct Polymorphs of Tau Aggregates Revealed by Nanoscale Infrared Spectroscopy. Banerjee S; Ghosh A J Phys Chem Lett; 2021 Nov; 12(45):11035-11041. PubMed ID: 34747175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]